Genetic Study of Amyotrophic Lateral Sclerosis in Norway
ConditionAmyotrophic Lateral Sclerosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16-100
SponsorSykehuset Telemark
About this trial
The purpose of this study is to explore the genetic causes relevant for ALS development in Norway.
Eligibility criteria
Qualifiers
Probable or definite ALS
Eligible to consent
Disqualifiers
None
Trial design
Treatments tested in this trial
- Observation
Treatment groups
1,200 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov